Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
about
sameAs
FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathwayThe Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartmentsFANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathwayThe Fanconi anemia gene product FANCF is a flexible adaptor proteinPhosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.FANCG is phosphorylated at serines 383 and 387 during mitosisATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway functionFanconi anemia proteins and their interacting partners: a molecular puzzleRecent advances in the understanding and management of MYH9-related inherited thrombocytopenias.Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repairOrigin, functional role, and clinical impact of Fanconi anemia FANCA mutations.Human Fanconi anemia complementation group a protein stimulates the 5' flap endonuclease activity of FEN1.Fanconi anaemia and leukaemia - clinical and molecular aspects.Evidence for subcomplexes in the Fanconi anemia pathway.FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients.Fanconi anemia A is a nucleocytoplasmic shuttling molecule required for gonadotropin-releasing hormone (GnRH) transduction of the GnRH receptorFanconi anaemia genes and susceptibility to cancer.Paternal or Maternal Uniparental Disomy of Chromosome 16 Resulting in Homozygosity of a Mutant Allele Causes Fanconi AnemiaThe Fanconi anemia protein interaction network: casting a wide net.Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.Maintenance of genome stability by Fanconi anemia proteins.HSP90 Shapes the Consequences of Human Genetic Variation.Validation of Fanconi anemia complementation Group A assignment using molecular analysis.Gonadotropin-releasing hormone regulates expression of the DNA damage repair gene, Fanconi anemia A, in pituitary gonadotroph cellsA germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.Towards a molecular understanding of the fanconi anemia core complexMyeloid lineage-selective growth of revertant cells in Fanconi anaemia.Mutations in Fanconi anemia genes and the risk of esophageal cancer.A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families.D1359Y mutation in a patient with gastric polyposis and cancer susceptibility: A case report and review of literature
P2860
Q24305406-48B457E0-08EF-4575-A5D2-E01B87B4A0F9Q28256288-A20C1729-5633-4F89-A851-F60339EE1421Q28269431-06CB3179-69C5-4269-87FA-6E7658B6149CQ28272859-96641521-5A18-4877-9F63-4B463BBD4CC6Q30434133-D612E99E-0097-448F-80BF-AA478B967F42Q30434487-859874CB-DB2B-4CB1-971B-3ABF5DFA7719Q30436823-B6872C68-61F6-48B7-AC10-432528410ECDQ33353826-19D7BEFA-5EB7-4DF2-ACFA-0B727009C7D9Q33395195-F38D3B82-5134-4B16-8F5D-350DEE5E4714Q33695948-C2A7F2F3-D31F-403F-8B1E-8624904984BBQ34707348-BBE62F09-6619-4307-BB78-137058F0F63EQ34870512-0942A69D-9C02-444D-ADA5-317549B6D45AQ35070427-C8B0FC47-7B88-453E-AD3C-36ED951E9A7FQ35828191-2BBCEFF6-6FA6-4CDF-B8EB-05464E5AA2FAQ35849094-A1B47C60-5F4A-4F65-94F2-250529CFC555Q35901424-303FE470-8910-472A-94C6-D0B6D884A877Q35989183-5F261899-8EE5-4979-894F-9148EB7D5A55Q36602573-7BE32F90-B2BD-4372-92EE-6BFD18E306F7Q36803584-4E4B3785-98A8-49F6-A4D0-8A98FD803E31Q37356265-421EABBE-B90D-4FB2-8AA7-C42F800662E1Q37384036-80065008-8027-4C98-A298-CD3DF653B0ECQ37658498-58D6EF4C-17DB-47FF-BCE9-E7B498A46549Q38953212-2E2F1425-19E0-4B29-92E9-168B622FAAE6Q39861009-54FB6990-E5CE-4BB9-9EE1-19D309B6D043Q40558834-48A54FAC-4181-470B-84C7-9E92E560515BQ41369694-F6BA3B4C-602D-4511-84F3-6C3513762461Q42182034-E4992965-0CB1-42E8-A66A-762E4DAAD4F3Q43559622-2D5567E5-B50B-45EB-992C-204AA60873C2Q47857337-1F2A602A-587D-493B-83E7-50B222A88D02Q48370083-1D5DD2C5-2F7E-4C3F-ADD6-D671D43CC229Q57815090-4012EC42-E57E-46D6-97E0-3A7AC24BCFA1
P2860
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@ast
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@en
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@nl
type
label
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@ast
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@en
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@nl
prefLabel
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@ast
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@en
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@nl
P2093
P356
P1476
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants
@en
P2093
Alan D D'Andrea
Daiki Adachi
Hiroshi Yagasaki
Keiko Nakasato
Shigetaka Asano
Takayuki Yamashita
Toshiyasu Taniguchi
Tsukasa Oda
P304
P356
10.1093/HMG/11.25.3125
P407
P577
2002-12-01T00:00:00Z